Steven Nissen, MD
Steven Nissen, MD is Chairman of the Department of Cardiovascular Medicine at Cleveland Clinic. Dr. Nissen came to Cleveland Clinic in 1992. National leadership positions include a term as President of the American College of Cardiology (ACC), the professional society representing American cardiologists (March 2006 to March 2007).
Dr. Nissen served as a member of the CardioRenal Advisory Panel of the Food and Drug Administration (FDA) for 5 yrs, and served as Chairman the final year of his membership. He continues to serve as Advisor to several FDA committees as ‘Special Government Employee’. In July 2008, while serving as guest member of the Endocrine and Metabolism Advisory Panel, Dr. Nissen recommended a new approach for approval of diabetes drugs, which was ultimately adopted by the Agency in November 2008.
Steven Nissen is also known for his role in public policy discussions, particularly in the area of drug safety. He has testified in both the Senate (Health Education and Labor Committee) and House of Representatives (Energy and Commerce Committee) on the need to reform the FDA. He was actively involved in discussions with Congress on the FDA Amendments Act of 2007 that added additional regulatory authority for the Agency.